改良六因子衰弱指数提升翻修全髋关节置换术风险分层
本研究基于2015至2020年ACS NSQIP数据库的10,040例翻修全髋关节置换术患者,比较mFI-5与新增低白蛋白血症(<3.5 g/dL)条目的mFI-6对30天不良结局的区分度。结果显示mFI-6在任一不良结局、再手术、再入院、死亡和伤口并发症的AUC均高于mFI-5(均调整P<0.001),且低白蛋白水平与不良结局风险升高相关。
要点
- mFI-6对30天任一不良结局的AUC为0.618,高于mFI-5的0.570(调整P<0.001)。
- 轻度低白蛋白血症在各衰弱分层中与任一不良结局风险升高2.56至3.27倍相关。
- 重度低白蛋白血症与任一不良结局风险升高3.56至8.98倍相关。
核心结论
- 在翻修全髋关节置换术中,mFI-6较mFI-5提供额外的预测价值,白蛋白水平越差风险越高。
研究设计与样本
- 回顾性队列研究,使用ACS NSQIP 2015至2020年数据,纳入10,040例接受翻修全髋关节置换术的成人。
主要发现
- mFI-6对任一不良结局的AUC为0.618,mFI-5为0.570;再手术为0.574对0.549;再入院为0.588对0.563;死亡为0.757对0.687;伤口并发症为0.575对0.541(均调整P<0.001)。
- 轻度低白蛋白血症(2.5至<3.5 g/dL)在各衰弱分层中与任一不良结局风险升高2.56至3.27倍相关。
- 重度低白蛋白血症(<2.5 g/dL)与任一不良结局风险升高3.56至8.98倍相关,次要结局呈相似模式。
关键数值与推荐
- mFI-6在mFI-5基础上新增低白蛋白血症(<3.5 g/dL)计1分。
- 低白蛋白血症分层:轻度2.5至<3.5 g/dL,重度<2.5 g/dL。
- 衰弱分层:非衰弱(mFI-5=0)、前衰弱(mFI-5=1)、衰弱(mFI-5≥2)。
临床怎么用
- 在翻修全髋关节置换术前评估中,可考虑将白蛋白纳入衰弱评估以改善风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The 5-item modified frailty index (mFI-5) estimates perioperative risk in revision total hip arthroplasty (rTHA), but may miss nutritional vulnerability. We evaluated a novel six-item extension (mFI-6) and hypothesized that adding a point for hypoalbuminemia (less than 3.5 g/dL) would improve discrimination for 30-day adverse outcomes after rTHA. METHODS: We performed a retrospective cohort study of adults undergoing rTHA (procedure codes 27134, 27137, and 27138) using the American College of Surgeons National Surgical Quality Improvement Program from 2015 to 2020. After excluding patients who had missing data for mFI-5-defining variables, albumin, body mass index, or key perioperative variables, 10,040 cases were analyzed. The discrimination of mFI-5 versus mFI-6 was compared using areas under the receiver operating characteristic curves. Multivariable logistic regression analyses assessed associations of mild (2.5 to less than 3.5 g/dL) and severe (less than 2.5 g/dL) hypoalbuminemia with 30-day outcomes across mFI-5 nonfrail (0), prefrail (1), and frail (≥ 2) strata. RESULTS: The mFI-6 demonstrated greater discrimination than mFI-5 for any adverse outcome (area under the curve, 0.618 versus 0.570), reoperation (0.574 versus 0.549), readmission (0.588 versus 0.563), mortality (0.757 versus 0.687), and wound complications (0.575 versus 0.541; all adjusted P < 0.001). Mild hypoalbuminemia was associated with 2.56- to 3.27-fold higher odds of any adverse outcome across frailty strata, whereas severe hypoalbuminemia was associated with 3.56- to 8.98-fold higher odds. Similar patterns were observed across secondary outcomes. CONCLUSIONS: The mFI-6 provided predictive value beyond mFI-5 alone in rTHA, with worsening albumin levels associated with progressively higher risk across frailty strata. Incorporating albumin into the frailty assessment may improve preoperative risk stratification for rTHA.
引用
- Swaminathan N, Welsh CE, Wagner PC, et al. A Modified 6-Factor Frailty Index Enhances Risk Stratification in Revision Total Hip Arthroplasty. J Arthroplasty. 2026. PMID: 42777887. doi:10.1016/j.arth.2026.09.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。